• Wiley Online Library will be disrupted on 26 May from 10:00-12:00 BST (05:00-07:00 EDT) for essential maintenance

Chapter 14. Structure-Based Drug Discovery

  1. Ralph Rapley3,
  2. Stuart Harbron4
  1. Chen-Chen Kan1,
  2. Kevin Hambly2,
  3. Derek A. Debe2

Published Online: 27 SEP 2005

DOI: 10.1002/0470020202.ch14

Molecular Analysis and Genome Discovery

Molecular Analysis and Genome Discovery

How to Cite

Kan, C.-C., Hambly, K. and Debe, D. A. (2005) Structure-Based Drug Discovery, in Molecular Analysis and Genome Discovery (eds R. Rapley and S. Harbron), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470020202.ch14

Editor Information

  1. 3

    University of Hertfordshire, UK

  2. 4

    The Enzyme Technology Consultancy, UK

Author Information

  1. 1

    Keck Graduate Institute of Applied Life Sciences, 535 Watson Dr., Claremont, CA, USA, and Eidogen, 1055 East Colorado Blvd, Suite 550, Pasadena, CA 81106, USA

  2. 2

    Eidogen, 1055 East Colorado Blvd, Suite 550, Pasadena, CA 81106, USA

Publication History

  1. Published Online: 27 SEP 2005
  2. Published Print: 23 APR 2004

ISBN Information

Print ISBN: 9780471499190

Online ISBN: 9780470020203

SEARCH

Keywords:

  • drug discovery;
  • dihydrofolate reductase (DHFR);
  • Chinese Hamster Ovary (CHO);
  • X-ray crystallography;
  • inosine monophosphate dehydrogenase (IMPDH);
  • computational structural proteomics

Summary

This chapter contains sections titled:

  • Overview of drug discovery and development

  • Principles of structure-based drug discovery

  • Case studies of structure-based drug discovery

  • Structure-based drug discovery in the post-genomic era

  • Acknowledgements

  • References